Header Logo

Connection

PATRICIA BAXTER to Bevacizumab

Back to Details
This is a "connection" page, showing publications PATRICIA BAXTER has written about Bevacizumab.
PATRICIA BAXTER
Connection Strength
0.043
Bevacizumab
  1. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.